In a recent transaction, James W. Liken, a director at Vapotherm Inc (NYSE:OTC:), a company specializing in surgical and medical instruments, sold shares of the company’s common stock. On January 22, 2024, Liken sold 17,500 shares at a weighted average price of $0.9118 per share, totaling approximately $15,956.
Additionally, on September 20, 2024, Liken disposed of 50,308 shares at a price of $2.18 per share, as well as an additional 4,500 shares at the same price. These disposals, related to a merger agreement, resulted in a total of $119,481.
The transactions were disclosed in a regulatory filing with the Securities and Exchange Commission. Following the sales and disposals, it appears that Liken no longer holds any shares of Vapotherm’s common stock. The reported prices for the shares sold and disposed of ranged from $0.88 to $0.92 and were at a fixed price of $2.18 per share, respectively.
Investors and interested parties can obtain further details regarding the number of shares sold at each separate price upon request, as indicated in the footnotes accompanying the SEC filing. The footnotes also explain that the disposals were part of a merger agreement which involved a cash payment for each share.
Vapotherm’s stock transactions by insiders are closely watched by investors as they provide insights into the company’s performance and insiders’ perspectives on the stock’s value.
InvestingPro Insights
As investors scrutinize the recent insider transactions at Vapotherm Inc (NYSE:VAPO), it’s important to consider the company’s financial health and market performance. Vapotherm, known for its medical and surgical instruments, has a market capitalization of $13.59 million, indicating a small-cap stock which could be subject to higher volatility and unique market risks.
InvestingPro data reveals that Vapotherm has had a significant price increase of 64.08% over the last six months, showcasing a notable surge in stock value. This price movement is consistent with the InvestingPro Tip that the stock has experienced a large price uptick in a similar timeframe. This tip is especially relevant as it coincides with the period leading up to the insider transactions conducted by James W. Liken.
Another InvestingPro Tip to consider is that Vapotherm operates with a significant debt burden and has been quickly burning through cash. These factors are crucial for investors to weigh against the recent insider sales, as they might reflect on the company’s financial strategy and liquidity concerns. Additionally, Vapotherm’s short-term obligations exceed its liquid assets, which could signal potential liquidity constraints in the near future.
For those interested in further insights, InvestingPro offers additional tips on Vapotherm, which can provide a deeper understanding of the company’s financial position and stock performance. There are currently nine additional tips listed on InvestingPro for Vapotherm, which can be accessed by visiting the dedicated page for the company’s metrics and analysis.
While the recent insider sales by Liken have drawn attention, these InvestingPro Insights can help investors form a more comprehensive view of Vapotherm’s current financial health and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
